FDA grants priority review for Pfizer, BioNTech COVID vaccine

FDA grants priority review for Pfizer, BioNTech COVID vaccine

Currently, Pfizer and BioNTech’s COVID-19 vaccine has Emergency Use Authorization (EAU) in the United States for individuals 12 and older.

6
Upvote
Save

Comments

Write a comment

*